Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development
Metrics: PDF 1012 views | ?
1 Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
3 Department of Medical Ultrasonics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
4 Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
5 Pittsburgh Liver Research Center, University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine, Pittsburgh PA, USA
6 Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, CA, USA
7 Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
* These authors have contributed equally to this work
Published: September 24, 2019
This article has been corrected: The correct author information is given below:
Satdarshan P. Monga
Original article: Oncotarget. 2019; 10:1475-1490. DOI: https://doi.org/10.18632/oncotarget.26668.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.